A critical advance in cancer study is arising with the use of VHH fragments to reactivate dysfunctional p53. This essential malignant inhibitor protein is frequently inactivated in several types of tumors, leading https://wisesocialsmedia.com/story7483545/mini-antibodies-revive-p53-new-new-hope-for-cancer-treatment